|
DIAPH2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.664250E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.496600E-01 |
| Normal-vs-Stage2 |
6.082400E-01 |
| Normal-vs-Stage3 |
8.713600E-02 |
| Normal-vs-Stage4 |
1.024040E-01 |
| Stage1-vs-Stage2 |
8.423400E-01 |
| Stage1-vs-Stage3 |
3.973800E-01 |
| Stage1-vs-Stage4 |
3.441400E-01 |
| Stage2-vs-Stage3 |
8.297600E-01 |
| Stage2-vs-Stage4 |
7.380200E-01 |
| Stage3-vs-Stage4 |
8.049800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.283800E-01 |
| Normal-vs-AfricanAmerican |
1.488020E-02 |
| Normal-vs-Asian |
7.605900E-04 |
| Caucasian-vs-AfricanAmerican |
6.198000E-02 |
| Caucasian-vs-Asian |
6.323300E-03 |
| AfricanAmerican-vs-Asian |
7.879400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.178200E-02 |
| Normal-vs-Female |
3.932600E-01 |
| Male-vs-Female |
1.643610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.369400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.099700E-03 |
| Normal-vs-Age(61-80Yrs) |
6.300000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.991600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.408000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.609600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.254800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.071600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.317000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.702000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.651400E-01 |
| Classical-VS-Follicular |
1.467820E-02 |
| Classical-VS-Other |
9.51740000000312E-05 |
| Classical-VS-Normal |
7.588200E-01 |
| Tall-VS-Follicular |
1.678160E-01 |
| Tall-VS-Other |
1.578930E-03 |
| Tall-VS-Normal |
6.145400E-01 |
| Follicular-VS-Other |
2.271900E-02 |
| Follicular-VS-Normal |
6.256900E-03 |
| Other-VS-Normal |
5.991300E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.933200E-01 |
| Normal-vs-N1 |
9.435800E-04 |
| N0-vs-N1 |
2.100100E-02 |
|
|
